Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 054789/0066 | |
| Pages: | 5 |
| | Recorded: | 10/14/2020 | | |
| Attorney Dkt #: | ASN-16-1580R2/393084-076 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE INSIDE THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED AT REEL: 043308 FRAME: 0524. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/25/2020
|
Application #:
|
15183504
|
Filing Dt:
|
06/15/2016
|
|
Publication #:
|
|
Pub Dt:
|
12/15/2016
| | | | |
|
Title:
|
HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATMENT OF CANCER
|
|
|
Assignee
|
|
|
|
|
| 1009 LENOX DRIVE |
| SUITE 106, PRINCETON PIKE CORPORATE CENTER |
| LAWRENCEVILLE, NEW JERSEY 08648 |
|
|
Correspondence name and address
|
| |
IP GROUP OF DLA PIPER LLP (US)
|
| |
ONE LIBERTY PLACE
|
| |
1650 MARKET STREET, SUITE 5000
|
| |
PHILADELPHIA, PA 19103
|
Search Results as of:
05/26/2024 06:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
